INS and obesity due to melanocortin 4 receptor deficiency: A systematic review of all three randomized placebo-controlled studies to treat obesity published to date found no impact of FMT on obesity, fasting plasma glucose, hepatic insulin sensitivity, or cholesterol markers across all included studies [75].